Create Free Account

By creating account you will get access to hot stocks & personalised emails

Artrya Ltd

Healthcare AU AYA

0.865AUD
-0.06(6.49%)

Last update at 2025-01-21T03:29:00Z

Day Range

0.860.93
LowHigh

52 Week Range

0.191.04
LowHigh

Fundamentals

  • Previous Close 0.93
  • Market Cap88.37M
  • Volume188137
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-13.95500M
  • Revenue TTM1.00M
  • Revenue Per Share TTM0.01
  • Gross Profit TTM -13.24600M
  • Diluted EPS TTM-0.18

Analyst Recommendations

Financials

Income Statement

Balancesheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Income before tax -11.11800M -16.62000M -4.07977M -1.35390M -0.14567M
Minority interest - - - - -
Net income -11.13600M -17.15500M -4.07977M -1.35390M -0.14567M
Selling general administrative 10.88M 8.98M 4.06M 1.72M 0.14M
Selling and marketing expenses - 1.70M - - -
Gross profit - - - - -
Reconciled depreciation 0.55M 0.20M - - -
Ebit -11.44600M -16.61300M -4.02900M -1.34730M -0.14600M
Ebitda -11.89000M -16.41100M - - -
Depreciation and amortization - 0.20M - - -
Non operating income net other - - - - -
Operating income -11.46400M -16.61300M -4.05302M -1.34730M -0.14566M
Other operating expenses 0.02M 16.79M 0.07M 0.38M 0.38M
Interest expense 0.02M 0.00700M 0.02M 0.00000M 0.00000M
Tax provision 0.02M 0.54M 0.00000M 0.00000M 0.00000M
Interest income 0.35M 0.07M 0.00182M 0.00053M 0.00000M
Net interest income 0.35M 0.05M - - -
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense 0.02M 0.54M - - -
Total revenue 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Total operating expenses - 16.79M - - -
Cost of revenue - - - - -
Total other income expense net 0.98M 0.11M - - -
Discontinued operations - - - - -
Net income from continuing ops -11.13600M -17.15500M - - -
Net income applicable to common shares -11.13600M -17.15500M -4.08000M -1.35390M -1.35390M
Preferred stock and other adjustments - - - - -
Breakdown 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Type yearly yearly yearly yearly yearly
Date 2024-06-30 2023-06-30 2022-06-30 2021-06-30 2020-06-30
Total assets 19.01M 33.09M 43.87M 52.22M 2.66M
Intangible assets - 7.17M 3.67M 0.52M -
Earning assets - - - - -
Other current assets 0.38M 0.15M - - -
Total liab 2.21M 2.53M 3.23M 1.17M 0.16M
Total stockholder equity 16.80M 30.56M 40.64M 51.05M 2.49M
Deferred long term liab - - - - -
Other current liab 1.05M 0.88M 1.39M 0.17M 0.09M
Common stock 56.45M 56.44M 56.40M 55.80M 3.98M
Capital stock - 56.44M 56.40M 55.80M -
Retained earnings -47.87200M -33.87200M -22.73600M 3.25M -1.50093M
Other liab - - 0.02M 0.00300M -
Good will - - - - -
Other assets - - - - -
Cash 7.28M 20.13M 15.29M 50.13M 2.23M
Cash and equivalents - - - - -
Total current liabilities 1.57M 1.59M 2.06M 1.16M 0.16M
Current deferred revenue - - - 0.17M -
Net debt -6.33372M - -13.91700M -50.07900M -
Short term debt 0.33M 0.00000M 0.22M 0.04M 0.00000M
Short long term debt - - - - -
Short long term debt total 0.95M - 1.37M 0.05M -
Other stockholder equity - 7.99M 6.98M 1.38M 0.02M
Property plant equipment - 2.21M 2.32M 0.14M 0.03M
Total current assets 11.54M 23.71M 37.87M 51.56M 2.63M
Long term investments - - - - -
Net tangible assets - 23.39M 36.97M 13.39M 2.49M
Short term investments 0.00028M 0.13M 20.27M - -
Net receivables 3.87M 3.07M 1.99M 1.43M 0.40M
Long term debt - - - - -
Inventory - - - - -
Accounts payable 0.20M 0.24M 0.45M 0.95M 0.02M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income 8.23M - 6.98M -8.00500M -
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 5.73M - - - -
Deferred long term asset charges - - - - -
Non current assets total 7.47M 9.38M 6.00M 0.66M -
Capital lease obligations - 1.21M 1.37M 0.05M -
Long term debt total - 0.94M 1.15M 0.00962M 0.00083M
Breakdown 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Type yearly yearly yearly yearly yearly
Date 2023-06-30 2022-06-30 2021-06-30 2020-06-30 2019-06-30
Investments 20.00M -20.27400M -20.27400M -20.27400M -
Change to liabilities -0.40800M 0.52M 0.84M 0.07M 0.00000M
Total cashflows from investing activities 16.27M -26.58600M -1.85700M -0.01548M -0.01548M
Net borrowings -0.26500M -0.10700M -0.03100M -0.01965M -0.01965M
Total cash from financing activities -0.24500M 38.53M 14.10M 2.96M 2.96M
Change to operating activities -0.17300M 0.20M 0.13M 0.03M 0.03M
Net income -11.13600M -17.15500M -4.08000M -1.35390M -0.14600M
Change in cash 4.85M 2.30M 10.75M 1.32M 1.32M
Begin period cash flow 15.29M 12.98M - - -
End period cash flow 20.13M 15.29M 12.98M - -
Total cash from operating activities -11.18500M -9.65100M -1.48700M -1.62301M -0.09600M
Issuance of capital stock 0.02M 40.01M - - -
Depreciation 0.52M 0.20M 0.04M 0.01M 0.01M
Other cashflows from investing activities 2.22M 0.07M 0.20M 0.20M 0.20M
Dividends paid - - - - -
Change to inventory - - - - -
Change to account receivables 0.43M 0.69M -1.03100M -0.39865M -0.39865M
Sale purchase of stock 0.02M -2.25300M 14.13M 2.98M 1.00M
Other cashflows from financing activities 0.00000M 0.78M -0.87100M -0.87100M -0.87108M
Change to netincome -0.45000M 5.89M 2.61M 0.02M 0.02M
Capital expenditures 0.29M 6.38M 0.09M 0.02M 0.00300M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.54M 0.97M 0.49M 0.02M -0.00001M
Stock based compensation - - - - -
Other non cash items - - - - -
Free cash flow -15.73800M -6.38000M - - -

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (AUD) Price (AUD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AYA
Artrya Ltd		 -0.06 6.49% 0.86 - - 23.69 4.59 - 0.33
PME
Pro Medicus Ltd		 4.49 1.74% 262.78 320.94 232.56 164.05 141.22 163.28 218.39
ONE
Oneview Healthcare PLC		 - -% 0.29 - - 24.33 27.78 14.38 -3.5247
CGS
CogState Ltd		 -0.03 2.61% 1.12 21.60 31.06 4.28 2.87 2.03 8.91
MDR
Medadvisor Ltd		 -0.005 2.44% 0.20 - 21.98 0.99 2.35 0.97 16.81

Reports Covered

Stock Research & News

View All

Profile

Artrya Limited, a medical technology company, engages in the development and commercialisation of artificial intelligence platform that detects, diagnoses, and address coronary artery disease in Australia. The company offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography scans which identifies and manages patients at risk of a heart attack. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.

Artrya Ltd

1257 Hay Street, West Perth, WA, Australia, 6005

Key Executives

Name Title Year Born
Mr. John Windsor Barrington A.M., F.A.C.I.D., M.B.A. Co-founder, CEO, MD & Director NA
Mr. John Konstantopoulos B.E. Co-Founder, Exec. Director of Product & Director NA
Mr. Mark Wainwright Chief Financial Officer NA
Dr. Julien Flack Chief Technology Officer NA
Prof. Girish Dwivedi M.D. Chief Scientific Officer NA
Ms. Janice Marcon Chief People & Culture Officer NA
Dr. Jacob Agris M.D., Ph.D. Chief Medical Officer NA
Mr. Riaz Kingston Head of Bus. Devel. NA
Dr. Jacque J. Sokolov B.A., M.D. Non-Exec. Director, Chair & Pres of Artrya USA Inc 1955
Mr. Ted Schwab Co-CEO of Artrya USA Inc NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.

Our Company

Useful Links

Contact Us

ISO Certified Market Research

Kalkine Solutions Private Limited, authorized representative of Kalkine Pty Ltd, holds ISO 27001:2022 certification bearing Certificate No.- IC-IS-2404072

Our Company

Useful Links

Contact Us

Disclaimer

The information given by Kalkine Pty Ltd ABN34 154 808 312 (Australian Financial Services License Number 425376) on this website is general information or advice only.

It does not take into account any of your personal objectives, circumstances or needs. Choosing an investment is an important decision. If you do not feel confident making a decision based on the recommendations Kalkine has made in our reports, you should consider obtaining personal advice from an authorised adviser.

There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. Terms & Conditions have been provided for our services, please go through them and also read our Financial Services Guide.

Our website may contain information on past performance of particular investments. Past performance is not an indicator of future performance. Hypothetical returns may not reflect actual performance. Any displays of potential investment opportunities are for sample purposes only and may not actually be available to investors.

The information on the website does not constitute an offer to sell securities or a solicitation of an offer to buy securities. Our reports contain general recommendations to invest in securities.

Copyright 2025 Krish Capital Pty. Ltd. All rights reserved. No part of this website, or its content, may be reproduced in any form without our prior consent.